SCHIERMEIER ANDREW 4
4 · Intellia Therapeutics, Inc. · Filed Mar 12, 2019
Insider Transaction Report
Form 4
SCHIERMEIER ANDREW
EVP, Dev and Corp Strategy
Transactions
- Purchase
Common Stock
2019-03-06$16.00/sh+3,250$52,000→ 3,250 total - Purchase
Common Stock
2019-03-06$15.50/sh+4,250$65,875→ 7,500 total
Holdings
- 8,644
Common Stock
Footnotes (1)
- [F1]Includes 1,091 and 53 shares acquired under the Intellia Therapeutics, Inc. 2016 Employee Stock Purchase Plan on June 30, 2018 and December 31, 2018, respectively.